Back to search

France· FR:62793782

SPIRAMYCINE EG 3 M.U.I., comprimé pelliculé

A spiramycin product containing spiramycine, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC J01FA02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSPIRAMYCINE EG 3 M.U.I., comprimé pel…ATCJ01FA02REGISTER NO.FR:62793782PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Spiramycin is registered in 9 of 19 countries.

Countries holding a registration under ATC J01FA02 (spiramycin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose

Spiramycin · ATC J01FA02

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SPIRAMYCINE
Manufacturer
EG LABO - LABORATOIRES EUROGENERICS
Country
France (FR)
ATC code
J01FA02
ATC class
Spiramycin
Defined daily dose
3 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400937634311
    plaquette(s) PVC PVDC aluminium de 10 comprimé(s)
    EUR 5.78
  • cip13
    3400937634489
    plaquette(s) PVC PVDC aluminium de 16 comprimé(s)
    EUR 9.22

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for spiramycin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Spiramycin · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Spiramycin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All spiramycin products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Rovamycine
  • Czechia · Rovamycine
  • Germany · Rovamycine, Selectomycin
  • Spain · Rovamycine
  • Italy · Rovamicina
  • Luxembourg · Rovamycine
  • Latvia · Rovamycine
  • Poland · Rovamycine
  • Portugal · Rovamycine
  • Romania · Rovamycine
  • Slovakia · Rovamycine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4786cec1-f7b0-4d7d-87b0-b40cbe54ed7c
GET /v1/drugs/4786cec1-f7b0-4d7d-87b0-b40cbe54ed7c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62793782",
  "date_amm": "2006-06-27",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SPIRAMYCINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about spiramycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.